Literature DB >> 24944064

Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration.

Lawrence M Knab1, Kazumi Ebine2, Christina R Chow3, Sania S Raza3, Vaibhav Sahai4, Akash P Patel4, Krishan Kumar2, David J Bentrem5, Paul J Grippo6, Hidayatullah G Munshi7.   

Abstract

UNLABELLED: Pancreatic ductal adenocarcinoma (PDAC) is associated with a pronounced fibro-inflammatory stromal reaction that contributes to tumor progression. A critical step in invasion and metastasis is the epithelial-to-mesenchymal transition (EMT), which can be regulated by the Snail family of transcription factors. Overexpression of Snail (Snai1) and mutant Kras(G12D) in the pancreas of transgenic mice, using an elastase (EL) promoter, resulted in fibrosis. To identify how Snail modulates inflammation in the pancreas, we examined the effect of expressing Snail in EL-Kras(G12D) mice (Kras(G12D)/Snail) on mast cell infiltration, which has been linked to PDAC progression. Using this animal model system, it was demonstrated that there are increased numbers of mast cells in the pancreas of Kras(G12D)/Snail mice compared with control Kras(G12D) mice. In addition, it was revealed that human primary PDAC tumors with increased Snail expression are associated with increased mast cell infiltration, and that Snail expression in these clinical specimens positively correlated with the expression of stem cell factor (SCF/KITLG), a cytokine known to regulate mast cell migration. Concomitantly, SCF levels are increased in the Kras(G12D)/Snail mice than in control mice. Moreover, overexpression of Snail in PDAC cells increased SCF levels, and the media conditioned by Snail-expressing PDAC cells promoted mast cell migration. Finally, inhibition of SCF using a neutralizing antibody significantly attenuated Snail-induced migration of mast cells. IMPLICATIONS: Together, these results elucidate how the EMT regulator Snail contributes to inflammation associated with PDAC tumors. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24944064      PMCID: PMC4201957          DOI: 10.1158/1541-7786.MCR-14-0111

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  42 in total

1.  Establishment of an immature mast cell line from a patient with mast cell leukemia.

Authors:  J H Butterfield; D Weiler; G Dewald; G J Gleich
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

2.  Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

Authors:  W R Sperr; J H Jordan; M Baghestanian; H P Kiener; P Samorapoompichit; H Semper; A Hauswirth; G H Schernthaner; A Chott; S Natter; D Kraft; R Valenta; L B Schwartz; K Geissler; K Lechner; P Valent
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

Review 3.  Dose accuracy and injection force dynamics of a novel disposable insulin pen.

Authors:  Alastair Clarke; Geralyn Spollett
Journal:  Expert Opin Drug Deliv       Date:  2007-03       Impact factor: 6.648

4.  Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney.

Authors:  Agnès Boutet; Cristina A De Frutos; Patrick H Maxwell; M José Mayol; J Romero; M Angela Nieto
Journal:  EMBO J       Date:  2006-11-09       Impact factor: 11.598

5.  Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.

Authors:  Adam J Ottaviano; Limin Sun; Vijayalakshmi Ananthanarayanan; Hidayatullah G Munshi
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

6.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Phenotypic characterization of the human mast-cell line HMC-1.

Authors:  G Nilsson; T Blom; M Kusche-Gullberg; L Kjellén; J H Butterfield; C Sundström; K Nilsson; L Hellman
Journal:  Scand J Immunol       Date:  1994-05       Impact factor: 3.487

8.  Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.

Authors:  Paul J Grippo; Patrick S Nowlin; Michael J Demeure; Daniel S Longnecker; Eric P Sandgren
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

9.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

10.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

Authors:  M G Bachem; E Schneider; H Gross; H Weidenbach; R M Schmid; A Menke; M Siech; H Beger; A Grünert; G Adler
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  10 in total

1.  BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.

Authors:  Krishan Kumar; Brian T DeCant; Paul J Grippo; Rosa F Hwang; David J Bentrem; Kazumi Ebine; Hidayatullah G Munshi
Journal:  JCI Insight       Date:  2017-02-09

2.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

Review 3.  [Tumor microenvironment--the critical element of tumor metastasis].

Authors:  Fang Yang; Yan Yu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-01

4.  Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells.

Authors:  Svenja Groeneveld; Julien Faget; Nadine Zangger; Etienne Meylan
Journal:  Oncotarget       Date:  2018-08-17

Review 5.  The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.

Authors:  Elisabetta Romeo; Carmelo Antonio Caserta; Cristiano Rumio; Fabrizio Marcucci
Journal:  Cells       Date:  2019-05-15       Impact factor: 6.600

6.  Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition.

Authors:  Yihsuan S Tsai; Mark G Woodcock; Salma H Azam; Leigh B Thorne; Krishna L Kanchi; Joel S Parker; Benjamin G Vincent; Chad V Pecot
Journal:  J Clin Invest       Date:  2022-02-15       Impact factor: 14.808

7.  TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1.

Authors:  Guillem Lambies; Martina Miceli; Catalina Martínez-Guillamon; Rubén Olivera-Salguero; Raúl Peña; Carolina-Paola Frías; Irene Calderón; Boyko S Atanassov; Sharon Y R Dent; Joaquín Arribas; Antonio García de Herreros; Víctor M Díaz
Journal:  Cancer Res       Date:  2018-10-19       Impact factor: 13.312

8.  PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.

Authors:  Neha Pincha; Edries Yousaf Hajam; Krithika Badarinath; Surya Prakash Rao Batta; Tafheem Masudi; Rakesh Dey; Peter Andreasen; Toshiaki Kawakami; Rekha Samuel; Renu George; Debashish Danda; Paul Mazhuvanchary Jacob; Colin Jamora
Journal:  J Clin Invest       Date:  2018-03-26       Impact factor: 19.456

9.  Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia.

Authors:  Kazumi Ebine; Christina R Chow; Brian T DeCant; Holly Z Hattaway; Paul J Grippo; Krishan Kumar; Hidayatullah G Munshi
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

Review 10.  Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents.

Authors:  Farid G Khalafalla; Mohammad W Khan
Journal:  Cancer Growth Metastasis       Date:  2017-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.